Fe3O4@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field.
Meichen LiuWeijia YuFuqiang ZhangTe LiuKai LiMeng LinYing WangGuoqing ZhaoJinlan JiangPublished in: International journal of nanomedicine (2021)
Fe3O4@PDA-labeled MSCs showed better homing to the spinal cord under magnetic field guidance. Moreover, they inhibited microglial and astrocyte activation, as well as played an early and continuous role in neuropathic pain treatment.